NEPH Nephros, Inc.

NAS · US · Healthcare · Medical Instruments & Supplies · nephros.com

3.200USD+5.96%Mkt Cap: 34.75M $P/E: 21.331d ago

Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers …

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc.

$146.44BUSDP/E 47.5

EssilorLuxottica Société anonyme

$73.12BUSDP/E 27.4

BDX

Becton, Dickinson and Company

West Pharmaceutical Services, Inc.

$25.79BUSDP/E 46.9

DIM

Sartorius Stedim Biotech S.A.

$23.14BUSDP/E 72.7

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.50BUSDP/E 73.0

SOLV

Solventum Corporation

$14.62BUSDP/E 10.5

BAX

Baxter International Inc.

The Cooper Companies, Inc.

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

ALGN

Align Technology, Inc.

Key Statistics

Company

Market Cap34.75M USD

Enterprise Value28.97M USD

Revenue (TTM)20.72M USD

Gross Profit11.63M USD

Net Income (TTM)1.19M USD

Revenue/Share1.94 USD

Last Price3.200 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees36

CountryUS

SectorHealthcare

IndustryMedical Instruments & Supplies

ISIN—

Valuation

P/E (Trailing)21.33

P/E (Forward)14.38

PEG—

EV/EBITDA16.43

EV/Revenue1.40

P/S1.58

P/B2.74

EPS (TTM)0.13

EPS (Forward)0.21

52W Range

2.66014% of range6.420

52W High6.420 USD

52W Low2.660 USD

Profitability

Gross Margin61.87%

Oper. Margin20.16%

EBITDA Margin8.51%

Profit Margin6.35%

ROE11.70%

ROA8.75%

Growth

Revenue Growth36.20%

Earnings Growth450.00%

Cash Flow & Leverage

Operating CF1.65M USD

CapEx (TTM)—

FCF Margin-7.00%

FCF Yield-4.18%

Net Debt-3.83M USD

Net Debt/EBITDA-2.17

Balance Sheet

Debt/Equity0.10

Current Ratio4.07

Quick Ratio2.63

Book Value/Sh1.10 USD

Cash/Share0.43 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay DateJul 10, 2019

Splits

Last Split1:9

Split DateJul 10, 2019

Analyst Consensus

Rating—

Target (Mean)6.250 USD

Upside (mean)+95.3%

Target Range4.750 USD – 8.000 USD

4.750+95.3% to mean8.000

# Analysts3

Ownership

Shares Out.10.86M

Float8.75M

Insiders18.74%

Institutions17.84%

Short Interest

Short Ratio1.4d

Short % Float0.69%

Short % Out.0.43%

Shares Short46.40K

Short (prev mo.)44.76K

Technical

SMA 504.103 (-22.0%)

SMA 2003.794 (-15.7%)

Beta1.64

S&P 52W Chg16.45%

Avg Vol (30d)34.44K

Avg Vol (10d)37.71K

Technical Indicators

RSI (14)33.8

MACD-0.2157

MACD Signal-0.0860

MACD Hist.-0.1297

BB Upper4.922 USD

BB Middle4.043 USD

BB Lower3.164 USD

BB Width43.48%

ATR (14)0.3364 USD

Vol Ratio (20d)1.53x